ANIP

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

ANI Pharmaceuticals, Inc. (ANIP) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B (3.2) C (2.4) B+ (3.6) C+ (2.7) C+ (2.6) B- (2.9)
2026-11-10 B (3.3) C (2.5) B+ (3.6) C+ (2.7) C+ (2.6) B- (2.9)
2026-11-03 B (3.2) B- (3.0) B+ (3.6) C (2.5) C+ (2.7) B- (3.0)
2026-10-27 B (3.2) B- (2.9) B+ (3.6) C (2.3) C+ (2.6) B- (2.9)
2026-10-20 B (3.2) B- (2.9) B+ (3.6) C (2.4) C+ (2.6) B- (3.0)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe